Yuan Hongjie, Yi Xiaobin
Department of Pain Medicine, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Pain Division, Department of Anesthesiology, Washington University in St Louis, St Louis, MO, USA.
J Pain Res. 2023 Nov 6;16:3707-3724. doi: 10.2147/JPR.S428112. eCollection 2023.
Lumbar spinal stenosis (LSS) is a common pain condition that causes lumbar back pain, radiating leg pain, and possible functional impairment. is an emerging minimally invasive treatment for LSS. It is an image-guided percutaneous procedure designed to debulk hypertrophied ligamentum flavum. However, the exact short- and long-term efficacy, safety profile, indication criteria, and certain procedure details reported in medical literature vary.
This narrative review was to elucidate efficacy, safety profile, certain procedure details, advantages, and limitations of
This is a narrative review.
All included articles are clinic trials including analytic studies and descriptive studies.
PubMed, Cochrane Library, and Scopus were searched. Only clinical trials of procedure were included. Information of indications, contraindications, VAS scores, ODI scores, effective rate, efficacy durations, and certain procedure details was focused on.
According to the literature, for the procedure, the VAS score could be reduced from a pre-treatment level of 6.3-9.6 to a post-treatment level of 2.3-5.8. The ODI score could be reduced from a pre-treatment level of 38.8-55.3 to a post-treatment level of 27.4-39.8. The effective rate of the procedure was reported to be 57.1%-88%. A 2-year postoperative stability of efficacy was also supported. One RCT study testified superior efficacy of over epidural steroid injection.
There is few high-quality literature in the review. Moreover, the long-term efficacy of cannot be revealed according to the current literature.
Based on the reviewed literature, is an effective and safe procedure. can reduce pain intensity and improve functional status significantly. Therefore, it is a preferable option for LSS patients who failed conservative treatments, but not for those who require immediate invasive decompression surgery.
腰椎管狭窄症（LSS）是一种常见的疼痛性疾病，可导致腰背痛、放射性腿痛以及可能的功能障碍。[具体治疗方法名称]是一种新兴的LSS微创治疗方法。它是一种在影像引导下的经皮手术，旨在切除肥厚的黄韧带。然而，医学文献中报道的确切短期和长期疗效、安全性、适应症标准以及某些手术细节各不相同。
本叙述性综述旨在阐明[具体治疗方法名称]的疗效、安全性、某些手术细节、优点和局限性。
这是一项叙述性综述。
所有纳入的文章均为临床试验，包括分析性研究和描述性研究。
检索了PubMed、Cochrane图书馆和Scopus。仅纳入了[具体治疗方法名称]手术的临床试验。重点关注适应症、禁忌症、视觉模拟评分（VAS）、日本骨科学会下腰痛评估量表（ODI）评分、有效率、疗效持续时间以及某些手术细节的信息。
根据文献，对于[具体治疗方法名称]手术，VAS评分可从治疗前的6.3 - 9.6降至治疗后的2.3 - 5.8。ODI评分可从治疗前的38.8 - 55.3降至治疗后的27.4 - 39.8。[具体治疗方法名称]手术的有效率据报道为57.1% - 88%。术后2年的疗效稳定性也得到了支持。一项随机对照试验（RCT）研究证明[具体治疗方法名称]比硬膜外类固醇注射疗效更优。
本综述中高质量文献较少。此外，根据当前文献无法揭示[具体治疗方法名称]的长期疗效。
基于所综述的文献，[具体治疗方法名称]是一种有效且安全的手术。它可以显著减轻疼痛强度并改善功能状态。因此，对于保守治疗失败的LSS患者而言，它是一个较好的选择，但对于那些需要立即进行侵入性减压手术的患者则不适用。
